2014
DOI: 10.1016/j.intimp.2013.12.004
|View full text |Cite
|
Sign up to set email alerts
|

Changes of CD4+CD25+FOXP3+ and CD8+CD28− regulatory T cells in non-small cell lung cancer patients undergoing surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
51
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 65 publications
(54 citation statements)
references
References 32 publications
0
51
1
Order By: Relevance
“…35 In another study in NSCLC patients, circulating Treg levels were also reduced 1–3 months after pneumectomy or lobectomy. 36 In contrast to these studies, in our study the Treg levels in blood were not significantly different between the P/D and no P/D groups three months after surgery. However, we analyzed only a limited number of patients, we could not study the effect of P/D on Tregs within the TME, preoperative data were not available and the P/D patients were at least three months after P/D.…”
Section: Discussioncontrasting
confidence: 96%
“…35 In another study in NSCLC patients, circulating Treg levels were also reduced 1–3 months after pneumectomy or lobectomy. 36 In contrast to these studies, in our study the Treg levels in blood were not significantly different between the P/D and no P/D groups three months after surgery. However, we analyzed only a limited number of patients, we could not study the effect of P/D on Tregs within the TME, preoperative data were not available and the P/D patients were at least three months after P/D.…”
Section: Discussioncontrasting
confidence: 96%
“…This may be due to the predominant use of lung cancer patients with early stage cancer: In previous studies, the percentages of T reg cells in patients with early stage cancer increased marginally or did not increase at all postoperatively [preoperative vs. postoperative: Stage I (2.34 vs. 1.77%), stage II (2.72 vs. 1.94%)], whereas the postoperative T reg percentage in patients with advanced stage (III+IV) cancer remained high (preoperative vs. postoperative: 1.61 vs. 3.52%) (29).…”
Section: Discussionmentioning
confidence: 98%
“…However, the balance between T-effector and T-regs in tumors is known to determine the functional outcome of immune responses [36], and both Th1/Treg and CD8/Treg ratios were lower in TT than in DNTT. Although the precise mechanism of Tregs-mediated suppression has yet to be fully elucidated [3739], at least part of the immunosuppressive effect may be could be exerted by CD39. This ectoenzyme serves as an integral component of the suppressive machinery of Tregs, inactivating and converting extracellular ATP into adenosine and allowing the immune escape of tumors [40–42].…”
Section: Discussionmentioning
confidence: 99%